ArticlePloS one2012

The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cells.

Gunter Rappl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.